Recommended in Primary care oncology

  • Clinical Essentials from BMC Cancer
  • 1 comment
  • FULLTEXT

Anxiety levels high in working age cancer survivors

The study suggests cancer survivors should be assessed for the presence of anxiety and depression.

Read more
  • Clinical Essentials from Gastroenterology
  • no comment

Statins reduce mortality in colon cancer

Read more
  • Vitals
  • 1 comment

Genitourinary Cancer Vitals for May 2017

Read more
  • Clinical Essentials from JAMA Intern Med
  • 1 comment
  • FULLTEXT

Decision-aid plus patient navigation support improves CRC screening rates

Read more
  • Clinical Essentials from Breast Cancer Res Treat
  • 1 comment

Childhood physical activity may lower breast cancer risk

Read more
  • Clinical Essentials from J Clin Oncol
  • 1 comment
  • FULLTEXT

Breast cancer: what do patients think of PCP involvement?

Read more
  • Clinical Essentials from JAMA
  • 1 comment
  • FULLTEXT

USPSTF recommends against routine thyroid cancer screening

Read more
  • Clinical Essentials from Gastroenterology
  • 1 comment

CRC: FIT tops FOBT with lower rate of interval cancer

Read more
  • Clinical Essentials from J Surg Res
  • 1 comment

PTC: increased risk for young and elderly patients

Read more

Professional Essentials

  • Patients Will Be Asking

How can I get my kid off juice?

Read more
  • Patients Will Be Asking

Are my child’s seasonal allergies more insidious than they seem?

Read more
  • US Professional News

Physician gets $5.4 million for whistleblowing

Read more
  • US Professional News

Alabama internist dies climbing Mount Everest

Read more
  • US Professional News

SC physicians unhappy about new volume-based compensation

Read more
  • US Professional News

California considers limits on pharma gifts

Read more
View more

New in Primary care oncology

  • Clinical Essentials from Urol Int
  • 1 comment

Testicular cancer: VTE risk high during cisplatin-based chemotherapy

Khorana risk score did not accurately predict risk of VTE.

Read more
  • Clinical Essentials from J Oncol Pract
  • 1 comment

Study supports illegal darbepoetin marketing claim

Settlements, fines, and repayments have amounted to $1.1 billion.

Read more
  • Clinical Essentials from JAMA Oncol
  • 1 comment

Prostate cancer: the value of combined urinary T2:ERG and PCA3 testing

Approach could significantly reduce unnecessary prostate biopsies.

Read more
  • Clinical Essentials from Nutrients
  • 1 comment

B vitamins may lower breast cancer risk in middle-aged women

Study shows benefit for dietary and supplemental intake of pyridoxine and thiamin.

Read more
  • Clinical Essentials from Perm J
  • 1 comment

Prostate cancer: smoking cessation boosts post-RP sexual function

Novel study evaluates the effects of quitting after cancer diagnosis.

Read more
  • Clinical Essentials from J Urol
  • 1 comment

Are urologists contributing to the opioid abuse epidemic?

Novel report quantifies rates of opioid dependence or overdose after urologic surgery.

Read more
  • Clinical Essentials from Oncotarget
  • 1 comment

NPC survival diminished by concurrent hypertension

Hypertension has been linked to poor outcomes for other cancer types

Read more
  • Clinical Essentials from Oncologist
  • 1 comment

Lymphoma raises risk for male breast cancer

Results of a SEER analysis.

Read more
  • Clinical Essentials from Support Care Cancer
  • 1 comment

Depressive symptoms in breast cancer survivors improve with lighter exercise

The findings may help inform physical activity recommendations for breast cancer survivors with depressive symptoms.

Read more
  • Clinical Essentials from J Clin Oncol
  • 1 comment

Localized prostate cancer: few men regret their treatment choices

15-y follow-up data from the Prostate Cancer Outcomes Study.

Read more
  • Clinical Essentials from Neurol Sci
  • 1 comment

Sleep quality may decline with androgen depletion therapy

Sleep quality in ADT has not been well studied to date.

Read more
  • Clinical Essentials from JAMA Oncol
  • 1 comment

Prostate cancer: luminal B tumors benefit most from post-op ADT

PAM50 classifier used to subtype breast cancer could guide personalized treatment.

Read more
  • Clinical Essentials from FDA
  • 1 comment

FDA approves second-line avelumab for urothelial carcinoma

Avelumab is the third PD-1/PD-L1 targeted therapy approved for mUC this year.

Read more
  • Clinical Essentials from J Urol
  • 1 comment

Prostate cancer: AUA issues White Paper on role of mpMRI

The American Urological Association’s recommendations are based on published data and expert consensus.

Read more